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1. Introduction 
Sentinel node biopsy (SNB) has become a standard surgical procedure for patients with early-
stage breast cancer. The sentinel nodes (SN) can be identified by a double-mapping procedure 
based on a gamma probe-guided method and a dye-guided method using a radioisotope (RI), 
or by a triple-mapping procedure that includes lymphoscintigraphy and is even more 
effective. However, the RI method can be performed only at institutions that are trained and 
licensed to use RI, and other institutions must rely on dye methods alone for SN identification. 
On the other hand, to obtain images of the lymph vessels and nodes, indirect lymphography 
seems to be a more convenient than direct intralymphatic administration of a contrast 
medium. Several studies of indirect lymphography were reported in the 1980s, and Suga et al. 
reported successfully identifying SN by 3-dimensional computed tomographic lymphography 
(CTLG) using a nonionic contrast medium. We have also been identifying SN in breast cancer 
patients by CTLG and a dye-guided method since February 2003 as a clinical trial. Here, we 
report our findings to date regarding the clinical efficacy and problems associated with SN 
identification by the combination of CTLG and a dye-guided method. 
2. Patients and methods 
All studies in this paper were approved by the ethics committee of National Hospital 
Organization Higashitokushima Medical Center. After presenting a detailed explanation of 
this clinical trial, written informed consent was obtained from all patients. 
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2.1 Patients 
During the period from February 2003 through March 2007, 218 Japanese patients  
with T1N0M0 or T2N0M0 primary breast cancer were treated at the Tokushima Breast  
Care Clinic. SN identification was performed by combined application of CTLG and a  
dye-guided method. In two of the patients the CTLG was performed before and after 
excisional biopsy, and in one patient with bilateral disease CTLG was performed on both 
sides. Thus, CTLG was performed 221 times in total, while the dye-guided method was 
performed a total of 219 times. In principle, backup dissection was performed for patients 
found to be SN metastasis-positive provided that informed consent was granted. For 
metastasis-negative patients, axillary dissection was omitted on the basis of informed 
consent. 
2.2 Methods 
CTLG was performed as previously described. Each patient was placed in the supine 
position, with the arms positioned upward but bent at the elbow with the hands at the 
side of the cranium. This position is similar to the surgical position. First, plain CT 
scanning of the affected axilla was carried out using a high-speed FX/i single-detector 
helical CT scanner (GE Yokogawa Medical Systems, Tokyo, Japan). The X-ray beam 
thickness was 3 mm and the pitch was 1.5. Then, one mL of iopamidol (Iopamiron 300; 
300 mgI/ml, Schering, Osaka, Japan) was injected subcutaneously (or intradermally) to 
the areola or both subcutaneously (or intradermally) to the areola and subcutaneously (or 
intradermally) above the tumor for a few minutes with a 26-gauge 5/8-inch hypodermic 
needle attached to a tuberculin syringe (Figure 1a). One minute after the injection, axillary 
CT scanning (CT lymphography) was done with the same thickness and pitch as 
described above. In the case that the enhancement of the lymph vessels and lymph nodes 
was poor, the site(s) where the contrast medium had been injected was gently massaged, 
and after 3-5 min the CT was repeated. Finally, the remaining medium ( about 99ml ) was 
intravenously administered from the unaffected forearm to examine distal metastases. A 
CT scanning was done in the thoracic and upper abdominal areas with 7mm beam 
thickness and 1.5 pitch in the axillary region with 3mm beam thickness and 1.5 pitch. 2-
dimensional images of axilla  (Figure 1b) were reconstructed at intervals of 1 mm, and 
then 3-dimensional images were created by the volume-rendered method to correlate 
with the surgical view (Figure 1c). SNs were predicted from CT images by identification 
of enhanced lymph vessels and/or lymph nodes and assessment of the CT values. The CT 
values of lymph nodes were measured at their maximally enhanced point. If an SN(s) was 
identified, a mark was made on the skin immediately above the SN by using an oil 
painting pen (Figure 1d).  
The dye-guided method was also performed as previously described. Briefly, 2~3 mL of 
indigo carmine blue was injected subcutaneously (or intradermally) to the areola, followed 
by massage of the injection site for a few minutes. Just before performing an operation, we 
used ultrasonography to confirm the location of SN(s) that has been identified by CTLG. 
Five to 15 min later a skin incision was made at the site(s) that were marked in the CTLG, 
and any blue-stained lymph vessels and lymph nodes were identified. If no SN(s) was 
identified by either the dye-guided method or CTLG, axillary lymph node dissection was 
performed. 
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Fig. 1. Method for identification of the SNs performed by CTLG. Images in patient with left 
breast cancer. (a) One ml of iopamidol was injected both subcutaneously (or intradermally) 
to the areola and subcutaneously (or intradermally) above the tumor. (b) Axial image 
demonstrating a tortuous, enhanced lymph vessel that reaches SN. (c) 3-dimensional CT 
lymphography image clearly showing an enhanced lymh vessel and an opacified SN (#1). 
(d) The mark was made on the skin immediately above the identificated SN by using an oil 
painting pen. 
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2.3 Definition of SNs 
CTLG: A lymph node was defined as an SN if visual inspection or the CT value (the increase 
of Hounsfield units after subcutaneous injection) confirmed it to be enhanced or if it was 
confirmed to connect to an enhanced lymph vessel.  
Dye-guided method: A lymph node was defined as an SN if it was dyed blue or if it was 
confirmed to connect to a blue lymph vessel.  
2.4 SN identification rates and the clinicopathological findings 
The results were analyzed in relation to the success/failure of SN identification and various 
clinicopathological parameters, including the patient age, menopausal status, body mass 
index (BMI), tumor diameter, presence/absence of excisional biopsy, histological type, 
presence/absence of lymph node metastasis and presence/absence of vascular invasion. 
2.5 Statistical analysis 
The relationships between the success/failure of SN identification and the 
clinicopathological findings were analyzed for statistical significance using the chi-square 
test. A p value of <0.05 was considered to indicate statistical significance. 
3. Results 
3.1 SN identification rates by CTLG and the dye-guided method 
Identification of the SN(s) was achieved in 212 (96%) of the total 221 performances of CTLG. 
The number of detected SNs ranged from 1 to 3, with a mean of 1.2 SNs. With the dye-
guided method the identification rate was 92% (202/219 tests). The combined identification 
rate was 99% (Table 1). 
 
 Dye CTLG Combination 
Lymph vessels 212 (97%) 202 (91%) 215 (98%) 
Sentinel nodes 202 (92%) 212 (96%) 216 (99%) 
Dye : Dye-guided method, CTLG : CT Lymphography, Combination : Combination of CTLG and Dye 
Table 1. Identification rates of lymph vessels and sentinel nodes 
With CTLG, both the lymph vessels and lymph nodes were clearly enhanced and the SNs 
could be identified in 189 patients (86%). In 5 patients (2%) the lymph vessels were not 
enhanced but the lymph nodes were, and the SNs could be identified. In 7 other patients 
(3%), the lymph vessels were enhanced while the lymph nodes were not clearly enhanced, 
but the SNs could be identified from the CT value. In 5 patients (2%) neither the lymph 
vessels nor the lymph nodes were enhanced, but the SNs could be identified from the CT 
value. In 6 patients (3%) the lymph vessels were enhanced but the lymph nodes were not, 
but the SNs could be identified on the basis of confirmation of their connection to the 
enhanced lymph vessels. Finally, in 9 patients (4%) neither the lymph vessels nor the lymph 
nodes were enhanced, and SNs could not be demonstrated (Table 2). 
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Lymph vessels Node  
Enhanced Cleary enhanced 189 (86%) 
Unenhanced Cleary enhanced 5 (2%) 
Enhanced Assessment of CT values 7 (3%) 
Unenhanced Assessment of CT values 5 (2%) 
Enhanced Unenhanced 6 (3%) 
Unenhanced Unenhanced 9 (4%) 
Table 2. Findings of CT lymphography (n=221) 
3.2 SN identification rates and the clinicopathological findings 
Analysis of the relationships between the SN identification rates and the clinicopathological 
findings showed that the SN identification rates with CTLG, the dye-guided method and the 
combined method showed no differences as a function of the age, menopausal status, tumor 
diameter or histopathological type. However, with the dye-guided method the SN 
identification rate was significantly lower in patients with a BMI of 25 or higher, whereas 
with CTLG and the combined method the SN identification rate was not influenced by the 
BMI. With CTLG and the combined method, the SN identification rate was significantly 
lower in the node-positive patients, and with the combined method it was significantly 
lower in patients with vascular invasion. In addition, in the patients who had undergone 
lateral-upper region excisional biopsy the SN identification rate with CTLG was lower than 
in the patients who had undergone excisional biopsy in a region other than the lateral-upper 
region, although the difference did not reach statistical significance. Moreover, with the dye-
guided method the SN identification rate was lower in the patients who had undergone 
excisional biopsy, regardless of the region, compared with the patients who had not 
undergone excisional biopsy (Table 3).  
 
 Dye (+), n=202
CTLG (+), 
n=212 
Combination (+), n=216 
Age (years) 
≤35 
36 - 50 
≥51 
 
6 (100%) 
87 (90%) 
109 (94%) 
 
6 (100%) 
92 (95%) 
114 (97%) 
 
6 (100%) 
96 (98%) 
114 (98%) 
Menopausal state 
Pre 
Post 
 
103 (92%) 
99 (93%) 
 
108 (96%) 
104 (95%) 
 
105 (98%) 
111 (99%) 
BMI 
<25 
≥25 
 
160 (95%) # 
42 (84%) 
 
164 (96%) 
48 (96%) 
 
166 (98%) 
50 (100%) 
Tumor size (cm) 
≤2.0 
>2.0 
 
183 (92%) 
19 (100%) 
 
193 (96%) 
19 (100%) 
 
197 (99%) 
19 (100%) 
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 Dye (+), n=202
CTLG (+), 
n=212 
Combination (+), n=216 
With excisionary biopsy * 
In lateral-upper region 
In other regions 
 
17 (89%) 
46 (88%) 
 
18 (95%) 
52 (100%) 
 
19 (100%) 
52 (100%) 
Histological type 
IIa1 
IIa2 
IIa3 
IIb3 
DCIS 
Others 
 
71 (88%) 
22 (100%) 
64 (96%) 
8 (89%) 
13 (100%) 
24 (89%) 
 
80 (99%) 
23 (100%) 
63 (94%) 
8 (89%) 
12 (92%) 
26 (93%) 
 
80 (99%) 
22 (100%) 
65 (97%) 
9 (100%) 
13 (100%) 
27 (100%) 
Nodal status 
n (-) 
n (+) 
 
177 (93%) 
25 (89%) 
 
189 (98%) # 
23 (82%) 
 
191 (100%) # 
25 (89%) 
Vascular invasion 
v (-) 
v (+) 
 
160 (91%) 
42 (95%) 
 
172 (97%) 
40 (91%) 
 
174 (99%) # 
42 (95%) 
BMI : Body mass index, Dye : Dye-guided method, CTLG : CT Lymphography, Combination : 
Combination of CTLG and Dye, # ; p<0.05, * ; cases with excisional biopsy (n=71) 
Table 3. Sentinel node(s) identification rate and clinicopathological findings (all cases) (Dye 
n=219, CTLG n=221, Combination n=219) 
3.3 Size of metastasis and the SN identification rate in node-positive patients 
The patients found to be positive for metastasis were classified and analyzed on the basis of 
the size of metastasis: <0.2 mm, 0.2mm~2mm and >2mm. The results showed that the SN 
identification rate by both CTLG and the dye-guided method decreased as the size of 
metastasis increased, although the difference did not reach statistical significance (Table 4). 
 
Metastatic lesion size Dye (+) CTLG (+) 
Isolated tumor cells ( <0.2 mm ) 2 (100%) 2 (100%) 
Micrometastasis ( 0.2 - 2 mm ) 10 (91%) 9 (82%) 
Macrometastasis ( ≥2.0 mm ) 13 (87%) 12 (80%) 
Dye : Dye-guided method, CTLG : CT Lymphography 
Table 4. Size of the metastatic lesion in the node positive cases (n=28)  
3.4 Number of lymph vessels leading to SNs and the number of SNs 
In this study, we were able to analyze the data on the lymph vessels leading to SNs and the 
number of SNs of 200 patients. A single route with a single SN was the most common 
pattern, seen in 68% of the patients. Multiple routes with a single SN were detected in 4% of 
the patients, while a single route with multiple SNs was seen in 10% and multiple routes 
with multiple SNs were seen in 8%. Overall, multiple SNs were identified in 18% of the 
patients (Table 5). 
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Single rout and single node 151 (68%) 
Multi routs and single node 8 (4%) 
Single rout and multi nodes 23 (10%) 
Multi routs and multi nodes 18 (8%) 
Table 5. Number of lymph vessels leading to sentinel nodes and the number of sentinel 
nodes 
4. Discussion 
In breast cancer surgery, dissection of the axillary lymph nodes is considered effective for 
the objectives of performing staging and achieving local control. Therefore, in recent years 
SNB has become a standard procedure for patients with no metastasis of the axillary lymph 
nodes since it avoids unnecessary dissection. Combined use of a RI (gamma probe-guided 
method and lymphoscintigraphy) and a dye is currently considered to be more efficient for 
identification of the SN(s) than the single use of either of these methods. In Japan, there are 
many institutions that do not have the necessary facilities for using RI and thus must use the 
dye-guided method alone to identify SNs. On the other hand, Suga et al. proposed using a 
method called CTLG, which employs a nonionic contrast medium, and we have applied that 
method for SN identification since February 2003. In this paper we have reported our 
findings regarding the usefulness and problems associated with combined application of 
CTLG and the dye-guided method for SN identification. 
Our experimental subjects were 219 Japanese patients with primary breast cancer that was 
thought to be clinically free of axillary lymph node metastasis. CTLG and the dye-guided 
method were employed in an attempt to identify the SN(s) in each of the patients. The SN 
identification rates were 96% with CTLG alone, 92% with the dye-guided method alone and 
99% when the findings with the two methods were combined. Those results are good when 
compared with the published data for  combined use of an RI and the dye-guided method. 
In particular, our SN identification rate with the dye-guided method is better than the rates 
that have been reported to date. We think that this is because the location of the SN had 
already been determined by the CTLG, making it easy to identify the lymph vessels and 
lymph nodes. The breakdown of the identification by CTLG showed clear enhancing of the 
lymph nodes in 88% of the patients, while in 5% of the patients identification of the SN was 
possible on the basis of the CT value in spite of the fact that the lymph nodes were not 
clearly enhanced. Because the observations were macroscopic, when the dye-guided method 
was used alone, SN identification was difficult unless the lymph node was stained to a 
sufficient degree. With CTLG, on the other hand, even if the enhancement is not very 
striking it can be surmised that the SN identification rate will be improved since the CT 
value can be taken into consideration. 
In 14 patients, the SN was identified by CTLG, but not by dye-guided method. The location 
of SN was confirmed by ultrasonography just before the operation in all of these patients. In 
these 14 patients, not only SN but also neighboring nodes were sampled at the same time. 
Therefore, it seemed that the SN biopsies had been performed accurately.  
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The sensitivity of CTLG could not be investigated in our patient population because 
backup axillary dissection was not performed for patients who were metastasis-negative 
in the SNB. In addition, none of the patients experienced postoperative recurrence in the 
axillary lymph nodes, but that does not serve as a basis for claiming that there were few 
false-negatives. However, Tangoku et al. reported the sensitivity of CTLG to be 98%, and 
for that reason it can be thought that the sensitivity of CTLG is not inferior to that of the 
RI method. 
With regard to correlations between the clinicopathological findings and the SN 
identification rate, the patient age, the location of the tumor, whether or not surgical biopsy 
was performed, the tumor size and the presence/absence of lymph node metastasis have 
been reported to influence the identification of the SN. In our patient series, the results 
showed no differences as a function of the age, menopausal status, tumor diameter or 
histopathological type. However, with the dye-guided method the SN identification rate 
was significantly lower in patients with a BMI of 25 or higher, whereas with CTLG and 
combination method the SN identification rate was not influenced by the BMI. As the reason 
for this difference, it is noted that with the dye-guided method it can be difficult to discern 
staining of lymph vessels and nodes with the naked eye if considerable subcutaneous fat is 
present, whereas with CTLG the subcutaneous fat plays no role since the observation is 
done by CT. In addition to the BMI, discrepancies between the SN identification rates with 
these three methods were observed as a function of the presence/absence of lymph node 
metastasis, the site of excisional biopsy (i.e., the lateral upper region and regions other than 
the lateral upper region), and the presence/absence of vascular invasion. Especially, the 
identification rates with CTLG and the combined method were significantly lower in node-
positive patients compared to node-negative patients, and significantly lower with the 
combined method in vascular invasion-positive patients compared to negative patients. The 
size of injected particles, the injected volume, the injection site have been reported as 
examination factors that can influence SN identification. The nonionic contrast media that 
are used in CTLG have a larger particle size than dyes. For that reason it can be 
hypothesized that, in patients with lymph node metastasis or vascular invasion and in 
patients who had undergone lateral upper region excisional biopsy, who can be predicted to 
have lymph vessel occlusion, the movement of a nonionic contrast medium would be 
impeded compared with that of a dye, thus resulting in a lower SN identification rate. On 
the other hand, the SN identification rate with the dye-guided method was lower in the 
patients with excisional biopsy in any region than in patients without excisional biopsy. It 
can be hypothesized that this is probably because excisional biopsy leads to edema of the 
connective tissue, which makes it difficult to distinguish the dye.  
We also investigated the number of SNs and the number of lymph vessels leading to them. 
These evaluations are difficult to achieve by the gamma probe-guided method and the dye-
guided method, but CTLG permits detailed investigation. Our results showed that there 
was a single route leading to a single SN in 68% of the patients, multiple routes leading to a 
single SN in 4%, a single route leading to multiple SNs in 10% and multiple routes leading 
to multiple SNs in 8%. These results are in agreement with those reported by Tangoku et al. 
Thus, approximately 18% of the patients in our series had multiple SNs, and it can be 
hypothesized that it would be difficult to biopsy all of them if only the dye-guided method 
were employed. We think that combined use of CTLG with the dye-guided method would 
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permit accurate biopsy, and for that reason we anticipate that combined performance of 
CTLG will prove useful.  
CTLG is a diagnostic test that is performed prior to surgery for breast cancer. Studies are 
warranted to determine whether the CT findings or performance of fine-needle aspiration 
cytology of the SN will make it possible to achieve diagnosis of SN metastasis 
preoperatively and then decide whether or not SNB should be performed. Such diagnosis 
leading to avoidance of unnecessary surgical procedures would represent a great clinical 
advantage by reducing the burden on the patient. Moreover, in the future it will be 
necessary to compare the usefulness of CTLG with the RI method. 
5. Conclusion 
Combined performance of CTLG with the dye-guided method permits better elucidation of 
the location of the SN(s) in breast cancer. This makes it easier to identify the SN(s) and 
results in a higher SN identification rate compared with application of the dye-guided 
method alone. Combination of CTLG and the dye-guided method was especially useful in 
obese patients. In addition, in patients with multiple SNs, it is advantageous to be able to 
perform SNB accurately. However, in patients with occlusion of the lymph vessels due to 
lymph node metastasis, having undergone lateral upper region lumpectomy or the presence 
of vascular invasion, there is a possibility that false-negative diagnostic results will be 
generated with CTLG.  
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